Edwards Lifesciences Corporation News
Cramer's Mad Money Recap 5/2: Coca-Cola, American Express, Visa
Investors can't wait for inflation to be broken before they buy.
Cramer's Mad Money Recap 2/1: Colgate-Palmolive, Stanley Black & Decker
Jim Cramer says stocks are caught between the forces of inflation and deflation, and investors need to find companies that can adapt.
Cramer's Mad Money Recap 12/8: Pfizer, Sweetgreen, Edwards Lifesciences
Jim Cramer reminds us the Dow has soared from 1,000 to 35,000 over the course of his career. That's quite a run, despite all the investor negativity.
'Mad Money' Lightning Round: Snap, Boston Scientific
Jim Cramer’s bullish on Snap, Boston Scientific and Cleveland-Cliffs.
Edward Lifesciences Hits Record High After Earnings Beat, TAVR Forecast
Edwards Lifesciences said its sees transcatheter aortic valve replacement (TAVR) sales rising as high as 20% this year.
Reopening Plays: Cramer's 'Mad Money' Recap (Monday 3/1/21)
Jim Cramers sifts through this relentless run in the reopening plays to find the less-obvious companies poised for profit.
Don't Bet Against the Bulls: Cramer's 'Mad Money' Recap (Thursday 12/10/20)
Despite the IPO euphoria, the backdrop to this market is just too optimistic to bet against the bulls, Jim Cramer says.
Vaccine Hopes: Cramer's 'Mad Money' Recap (Wednesday 7/15/20)
Jim Cramer says the markets are optimistic about a vaccine, but he cautions there’s a long way to go. We still need more stimulus.
Johnson & Johnson Stock Lower After Unveiling End To Global Baby Powder Sales In 2023
Johnson & Johnson, which began selling Baby Powder in 1894, will end all sales of the talc-based product next year.
Apple Stock Edges Higher After Report Indicates iPhone Demand Confidence
Apple is asking assemblers to put together 220 million iPhones this year, Bloomberg reported, a tally that largely matches 2021 levels.
Struggling Electric-Truck Maker Nikola Makes a Major Change
Electric-truck manufacturer Nikola, like the broad vehicle industry, has been struggling with supply-chain issues.